Table 2.
Examined nerve | Adjusted mean change in NCV (m/s) at T6 vs baseline | p valuea | |
---|---|---|---|
FREMS | Placebo | ||
ITT population | |||
Deep peroneal | 0.74 ± 0.71 | 0.06 ± 1.38 | NS |
Tibial | 2.08 ± 0.84 | 0.61 ± 0.43 | NS |
Sural | 0.80 ± 1.08 | −0.91 ± 1.13 | NS |
PP population | |||
Deep peroneal | 0.98 ± 0.72 | −0.05 ± 0.44 | 0.049 |
Tibial | 0.76 ± 0.59 | 0.58 ± 0.46 | NS |
Sural | 1.13 ± 0.87 | 0.44 ± 0.96 | NS |
Data are presented as means ± SE. ITT population: n = 50 (FREMS) and n = 51 (placebo); PP population: n = 39 (FREMS) and n = 36 (placebo). aGeneral mixed-effects model analysis